Impact of Intravenous Lidocaine During Colorectal Surgery on Pain and Immune Functions

Phase 4 Unknown 60 enrolled Ciusss de L'Est de l'Île de Montréal Foundation of Anesthesia and Resuscitation of Quebec · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the impact of intraoperative intravenous lidocaine administered during laparoscopic colorectal surgery on the intraoperative remifentanil consumption as well as postoperative pain and opioid requirements. It will evaluate immune cell activity for 48hours after surgical stress and general anesthesia with or without intravenous lidocaine.

Timeline

Start: 2019-04-29
Primary completion: 2024-12
Completion: 2025-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lidocaine	Other / unclassified	1.5 mg/kg	Intravenous

Indications

No indication recorded.